Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program
NEW YORK, Dec. 7, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced today that its Board of Directors recently authorized a new share repurchase program to acquire up to an additional $1 billion of the company's outstanding common shares.
Separately, the company also announced that in November it entered into an accelerated share repurchase agreement to acquire $150 million of Edwards' common stock. Upon entering into the agreement, Edwards received and retired an initial delivery of 1.1 million shares. In addition, earlier in the fourth quarter, Edwards repurchased approximately $100 million of common stock.
About Edwards Lifesciences Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. For more information, visit www.Edwards.com and follow us on Twitter @EdwardsLifesci.
S&P MidCap 400 constituent Vistra Corp. will replace Pioneer Natural Resources Co. in the S&P 500, S&P SmallCap 600 constituent Aaon Inc. (NASD: AAON) will replace Vistra in the S&P MidCap 400, and Marathon Digital Holdings Inc. (NASD: MARA) will...
Vizsla Silver Corp. ("Vizsla Silver" or the "Company") is pleased to announce that it has now issued 448,137 common shares (the "Consideration Shares") for the previously announced asset purchase agreement (the "Acquisition Agreement") dated March...
Frontenac Mortgage Investment Corporation ("FMIC") announces that it has filed amended and restated interim unaudited financial statements and related management's discussion and analysis ("MD&A") for the quarters ended March 31, 2023, June 30, 2023...
Capital Community Bank (CCBank), a leader in Utah community banking, is excited to announce the successful acquisition of Security Home Mortgage (SHM), a well-respected provider of home mortgage solutions since 1999. This landmark deal marks a...
Stellus Capital Investment Corporation will release its financial results for the first quarter ended March 31, 2024 on Thursday, May 9, 2024, after the close of the stock market....
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...
